510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
JLAClass I

Conversion To Creatinine, Creatine

21 CFR 862.1210 / Clinical Chemistry
FDA source (opens on fda.gov)

JLA is the FDA product code for Conversion To Creatinine, Creatine, a class I device type, regulated under 21 CFR 862.1210. As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and one recall.

Classification record

Product code
JLA
Device name
Conversion To Creatinine, Creatine
Regulation
21 CFR 862.1210
Device class
Class I
Review panel
Clinical Chemistry
Submission type
510(k) exempt
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
No
Ingested clearances
2
Ingested recalls
1

Clearances, product code JLA

By decision year
2 clearances under product code JLA with a decision year between 1986 and 1986, 1986 the highest year at 2.
Show the numbers
510(k) clearances under FDA product code JLA by decision year
YearClearances
19862

Applicants with the most clearances

Product code JLA
Applicants holding the most 510(k) clearances under product code JLA
ApplicantClearances
American Bioproducts Co.1
Panmed, Inc.1

Companies listing this code with FDA

Companies whose registered establishments list this code